BioXcel Therapeutics, Inc. (BTAI) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $0 | — |
| 2024 | $0 | -100.0% |
| 2023 | $20.0K | -85.6% |
| 2022 | $139.0K | -68.8% |
| 2021 | $445.0K | +40.8% |
| 2020 | $316.0K | -63.7% |
| 2019 | $870.0K | +155.9% |
| 2018 | $340.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $0 | — |
| 2024 | $0 | -100.0% |
| 2023 | $20.0K | -85.6% |
| 2022 | $139.0K | -68.8% |
| 2021 | $445.0K | +40.8% |
| 2020 | $316.0K | -63.7% |
| 2019 | $870.0K | +155.9% |
| 2018 | $340.0K | — |